Don't think this storage is feasible in our part of world.
----------------------------------------------------------------------

To keep the vaccines safe in transit and to move them fast, Pfizer designed a new reusable container that can keep the vaccine at ultracold temperatures for up to 10 days and hold between 1,000 and 5,000 doses. The suitcase-sized boxes, which are packed with dry ice and tracked by GPS, will enable Pfizer to avoid the larger, temperature-controlling containers used in transportation, giving it more flexibility to ship the vaccines faster since planes and trucks won’t have to wait for the standard refrigerated metal boxes.

This is what I do, buy and keep in drawer. Then go around goreng other counters for nasi ayam.

Penthouse was like 2 months ago...rental not cheap

Sell? For another few sen profit? Hahahahaha..

All watching Trump / Joe debate live now

Fly Kanger Fly

Fly Iris Fly, Up Up to the SKY....

If did not enter market, missed the boat...bad mood whole week, not just weekend. Hahahahaha.

Approx. RM 1500 x 10 million people (est. market share) = RM 15,000,000,000
Profit margin 10% = RM 1.5 billion.

Mind boggling.

"There are two shots, costing 2,600 yuan," he said, noting that shortly before the National Day holidays he was offered the Sinopharm vaccines..

This is a multi billion business. Ready market some more.

4 sen rise also have to run? How can? Wait until 40sen rise la. Then we fast fast run.

Reservations being taken for COVID-19 vaccine in Beijing, Wuhan: media reports

Source: Global Times Published: 2020/10/12 23:51:41


State-owned China National Pharmaceutical Group (Sinopharm) has launched an online reservation for people seeking COVID-19 vaccines in Beijing and Wuhan, Central China's Hubei Province, media reported on Monday.

Students who will travel abroad are among the priority groups being offered the Sinopharm coronavirus shot, according to the reports.

"We attach great importance to the students who study aboard, and hope to provide effective, safe and comprehensive insurance in line with the law," a source close to Sinopharm who asked not to be identified told the Global Times on Monday.

Students who study abroad, overseas staff and frontline workers are entitled to "urgent use" of the vaccines.

The Global Times reporter found on the reservation platform that students who are planning to travel abroad from November to January 2021 will be eligible to receive the shot.

Sinopharm said that they intend to provide Chinese students studying abroad the vaccines for free.

More than 152,000 people have made reservations for the vaccines while another 747,572 expressed willingness to take the vaccine as of Tuesday morning.

Meanwhile, the platform became inaccessible on Tuesday afternoon and Sinopharm has not responded to a request for confirmation as of press time on Monday.

A student who is set to study abroad for her master's degree said on Tuesday that she received a text after filling out the form online and was invited to a chat group with about 200 students who have registered for the vaccines.

"After joining the group, students are required to register a (concrete) time and place to take the shot. The earliest time available is around middle of October," the student who preferred not to be named told the Global Times.

Although she is still considering the option out of safety concerns, she confirmed to the Global Times that many students in the group had already registered for it.

Another student who is in another WeChat group for applicants in Wuhan told the Global Times on Tuesday that they were told the program in Wuhan had been suspended.

"I was informed by the visa agency in mid-September that we can make an appointment for Sinopharm vaccine shots in Beijing," an employee at an internet company in Beijing told the Global Times on condition of anonymity.

"There are two shots, costing 2,600 yuan," he said, noting that shortly before the National Day holidays he was offered the Sinopharm vaccines.

His job requires him to travel overseas countries, including India, which currently has the world's second-highest recorded COVID-19 infections.

"In our trade, you never know when the company needs you out there. You can also go overseas without the vaccine, but that's another story. And taking COVID-19 vaccines needs some time, so I am following the development closely," the person said.

Though the source close to Sinopharm claimed that there is still no exact timetable for groups taking emergency vaccination, the company has taken "reservations for vaccines" at the China International Fair for Trade in Services held in September,

The Chinese vaccine developer has two vaccine products that have already entered Phase III trial tests covering sample groups in 125 countries, according to Sinopharm. In line with the laws and regulations, the company received the approval for emergency use of the vaccine on July 22.

Must watch opening closely tomorrow. I am a greedy man Hahaha

I think our PM and Foreign Minister are on the same page when Chinese FM came to Malaysia 2 weeks ago in requesting vaccine to be priority for Malaysia.

Pharma and Dpharma both at RM 4 plus. That should be the target. Even at 50% discount, it is still RM 2 plus. Good enough for me.

Logically price should all at the Niis related counters ..1.30 - 1.50.

If it is Niis related, then .305 is still very cheap. I remembered the price when Iris announced the Indian Contract was 385.

This stock need holding power. Not for contra players. Just buy when price is low to average down. Thanks to NPRA, we know quite a bit on what we are getting into.

Gloves stock very volatile now

Wong will goreng until 1.50 only

It is not rumors. That's why Iris supporters are here to stay. We been holding on since 2 mths ago.

I think PP had been submitted. Max up for PP fund raising.

Come over to Iris. High volume and upside today

Someone is pushing up the prices. Definitely not retail players.

Support very strong at 295.

Bilis investor like me big hoohaaaa over 2 sen gain. LOL

Big battle at 285

There's a lot of difference between informed and hearsay decisions including investments.

Very high volume as of now ...105m

Already collected until eyebrow liao. Hahahaha...

Iris supporters have seen the ups and downs since August. We all know what it is called rubbish stock, rubbish talk and rubbish announcements.

Sinopharm is inactivated vaccine...means it use dead virus, not live ones like others. Know the difference.

Brazil death is a volunteer for AstraZenneca...and he was not given a shot yet.

Korea people died is vaccine is flu shot. Not Covid19 type.

Today can reach 30 easily

I am confident on this stock.

Niis lai liao

OK....28 liao

Nearly there...3rd trial so far is safe, it is halal, PP is now submitted, Umno is ok so Nur Jazlan can do magic...all we need is approvals in the coming weeks.

Stuck at 275

Interesting....climb

I only have little bit of shares, if prices go up, I happy keeping. If prices come down, I buy more. But at least here, I am investing with knowledge on vaccine development and its impacts.. I call this informed investment.

https://www.dailymail.co.uk/news/article-8843493/Chinese-experimental-Covid-19-vaccine-safe-produces-immune-response.html

Sinopharm uses inactivated viruses in their vaccine development. Which means the virus are dead, incapacitated to reproduce while many other Western vaccines use live germs in adenovirus vaccines. From a common man on street, isn't it logical to get yourself injected with dead virus over live ones? I am just wondering...

@NPRA TQ for the Halal info. I feel very comfortable with Kanger / Sinopharm.

Me too. Now averaged down to 193. Sit tight and wait for the marlin fish (patiently)

Big queue at 185.

I bought at .200, .195, average to 197 and now queue for .180.

BBB news already show normal Chinese queue up to get vaccine injection open market. IB know what is going to happen next.

https://www.channelnewsasia.com/news/asia/chinese-drugmaker-setting-up-covid-19-vaccine-production-lines-13321536